| AMRF | Action myoclonus-renal failure |
| CBE | Conduritol B epoxide |
| CCL18 | (C-C motif) ligand 18 |
| CNS | Central nervous system |
| CSF | Cerebrospinal fluid |
| ERT | Enzyme replacement therapy |
| GBA | Glucosylceramidase |
| GD | Gaucher disease |
| Hb | Hemoglobin |
| HPLC | High-performance liquid chromatography |
| HPTLC | High-performance thin-layer chromatography |
| LC/MS/MS | Liquid chromatography tandem mass spectrometry |
| Lyso-Gb1 | Glucosylsphingosine |
| NICE | National Institute for Health and Care Excellence |
| PRISMA-P | Preferred Items for Systematic Review and Meta-Analyses Protocols |
| RBC | Red blood cell |
| SRT | Substrate reduction therapy |
| STA | Single technology appraisal |
| SYRCLE | Systematic Review Centre for Laboratory animal Experimentation |
| TDAG8 | T cell death-associated gene 8 |
| TLC | Thin-layer chromatography. |